Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Myeloproliferative Disorders × Pharmaceutical Preparations × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 8 Neoplasms 7 Neoplasm Metastasis 5 Carcinoma, Non-Small-Cell Lung 5 Recurrence 4 Prostatic Neoplasms 4 Melanoma 4 Breast Neoplasms 4 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Polycystic Ovary Syndrome 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Head and Neck Neoplasms 2 Anxiety Disorders 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Rare Malignant Neoplasm 1 Pleural Effusion, Malignant 1 Pancreatic Neoplasms 1 Nephrotic Syndrome 1 Neoplasms, Plasma Cell 1 NSCLC 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1

Interventions

Cyclophosphamide 74 fludarabine phosphate 69 Peripheral Blood Stem Cell Transplantation 54 Mycophenolic Acid 46 Whole-Body Irradiation 45 Busulfan 45 Tacrolimus 44 Antilymphocyte Serum 39 fludarabine 37 Cyclosporine 36 Filgrastim 33 Cytarabine 29 Methotrexate 28 ruxolitinib 27 Melphalan 26 Radiotherapy 21 Etoposide 20 Azacitidine 19 Methylprednisolone 18 Sirolimus 14 Decitabine 14 Cord Blood Stem Cell Transplantation 14 Biopsy 14 Specimen Handling 13 Granulocyte Colony-Stimulating Factor 13 Flow Cytometry 13 thymoglobulin 12 venetoclax 11 Cyclosporins 11 Alemtuzumab 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04994158 2025-07-30

MASCOT-R

Royal Free Hospital NHS Foundation Trust

Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡